Calithera Biosciences Inc

Company Profile

Calithera Biosciences Inc had its IPO on 2014-10-02 under the ticker symbol CALA.

The company operates in the Healthcare sector and Biotechnology industry. Calithera Biosciences Inc has a staff strength of 8 employees.

Stock update

Shares of Calithera Biosciences Inc opened at $0.05 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.05 - $0.05, and closed at $0.05.

This is a 0% increase from the previous day's closing price.

A total volume of 733 shares were traded at the close of the day’s session.

In the last one week, shares of Calithera Biosciences Inc have increased by 0%.

Calithera Biosciences Inc's Key Ratios

Calithera Biosciences Inc has a market cap of $1.73 million, indicating a price to book ratio of 1.8639 and a price to sales ratio of 1.7108.

In the last 12-months Calithera Biosciences Inc’s revenue was $0 with a gross profit of $-42705000 and an EBITDA of $-41819000. The EBITDA ratio measures Calithera Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Calithera Biosciences Inc’s operating margin was 0% while its return on assets stood at -56.29% with a return of equity of -114.14%.

In Q4, Calithera Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Calithera Biosciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

-0.29

Its diluted EPS in the last 12-months stands at $-7.94 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -0.29. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Calithera Biosciences Inc’s profitability.

Calithera Biosciences Inc stock is trading at a EV to sales ratio of 0.0141 and a EV to EBITDA ratio of 0.0409. Its price to sales ratio in the trailing 12-months stood at 1.7108.

Calithera Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$28.68 million

Total Liabilities

$7.39 million

Operating Cash Flow

$0

Capital Expenditure

$23000

Dividend Payout Ratio

0%

Calithera Biosciences Inc ended 2024 with $28.68 million in total assets and $0 in total liabilities. Its intangible assets were valued at $28.68 million while shareholder equity stood at $20.39 million.

Calithera Biosciences Inc ended 2024 with $0 in deferred long-term liabilities, $7.39 million in other current liabilities, in common stock, $-512616000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $25.45 million and cash and short-term investments were $25.45 million. The company’s total short-term debt was $1,530,000 while long-term debt stood at $0.

Calithera Biosciences Inc’s total current assets stands at $26.62 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $732000.00 and inventory worth $0.

In 2024, Calithera Biosciences Inc's operating cash flow was $0 while its capital expenditure stood at $23000.

Comparatively, Calithera Biosciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.05

52-Week High

$5.1

52-Week Low

$0.01

Analyst Target Price

$5

Calithera Biosciences Inc stock is currently trading at $0.05 per share. It touched a 52-week high of $5.1 and a 52-week low of $5.1. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $0.05 and 200-day moving average was $0.47 The short ratio stood at 0.78 indicating a short percent outstanding of 0%.

Around 107.4% of the company’s stock are held by insiders while 2676.9% are held by institutions.